Andreas Barratt-Due Selected Research

Andreas Barratt-Due Research Topics

Disease

16	Inflammation (Inflammations) 12/2022 - 11/2011
15	COVID-19 03/2024 - 10/2020
14	Sepsis (Septicemia) 01/2023 - 03/2010
10	Respiratory Insufficiency (Respiratory Failure) 01/2024 - 12/2017
4	Thrombocytopenia (Thrombopenia) 12/2023 - 05/2022
4	Infections 01/2023 - 01/2017
3	Shock 12/2022 - 11/2011
3	Reperfusion Injury 01/2019 - 11/2012
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2024 - 01/2023
2	Critical Illness (Critically Ill) 12/2022 - 11/2019
2	Thrombosis (Thrombus) 05/2022 - 03/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 12/2017
1	Fetal Death 01/2024
1	Body Weight (Weight, Body) 01/2023
1	Liver Failure 12/2022
1	Hemorrhage 10/2022
1	Fibrosis (Cirrhosis) 05/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2021
1	Nervous System Trauma 10/2021
1	Thrombotic Microangiopathies 02/2021
1	Bacteremia 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Thrombotic Thrombocytopenic Purpura 11/2019
1	Thromboinflammation 01/2019
1	Hemolysis 01/2019
1	Non-ST Elevated Myocardial Infarction 01/2018
1	Myocardial Infarction 01/2018
1	Cardiogenic Shock 01/2018
1	Heart Failure 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	ST Elevation Myocardial Infarction 01/2018
1	Neoplasms (Cancer) 12/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2017
1	Disease Progression 01/2017
1	Hereditary Complement Deficiency Diseases 01/2017
1	Cytokine Release Syndrome 06/2014

Drug/Important Bio-Agent (IBA)

16	Complement System Proteins (Complement)IBA 03/2024 - 11/2012
6	remdesivirIBA 01/2024 - 01/2021
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2024 - 01/2021
4	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2021
4	Oxygen (Dioxygen)IBA 01/2023 - 10/2020
4	CytokinesIBA 01/2017 - 05/2010
3	Hemostatics (Antihemorrhagics)IBA 01/2024 - 03/2010
3	InterferonsIBA 01/2023 - 11/2021
3	AntibodiesIBA 05/2022 - 11/2013
3	Complement Inactivating AgentsIBA 10/2020 - 07/2013
3	Complement C5 (Complement 5)IBA 01/2018 - 07/2013
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 08/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2021
2	eculizumab FDA Link 02/2021 - 03/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2017
2	Immunoglobulin G (IgG)IBA 11/2013 - 05/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 03/2010
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2024
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2024
1	EnzymesIBA 01/2024
1	S100A12 ProteinIBA 12/2023
1	COVID-19 VaccinesIBA 12/2022
1	ChemokinesIBA 12/2022
1	OsteopontinIBA 05/2022
1	Ferritins (Ferritin)IBA 05/2022
1	Heparin (Liquaemin)FDA LinkGeneric 05/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2021
1	Interferon beta-1a FDA Link 11/2021
1	Lopinavir FDA Link 11/2021
1	Glial Fibrillary Acidic ProteinIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Complement Factor B (Factor B)IBA 02/2021
1	CoagulaseIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	thiamine triphosphorate (TTP)IBA 11/2019
1	HaptoglobinsIBA 01/2019
1	HemopexinIBA 01/2019
1	Heme (Haem)IBA 01/2019
1	AntigensIBA 01/2019
1	Prothrombin (Factor II)IBA 01/2019
1	tocilizumab (atlizumab)FDA Link 01/2018
1	Anaphylatoxin C5a ReceptorIBA 01/2018
1	AnaphylatoxinsIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Simendan (Levosimendan)IBA 01/2018

Therapy/Procedure

8	Therapeutics 01/2023 - 09/2013
5	Artificial Respiration (Mechanical Ventilation) 01/2024 - 12/2017
4	Critical Care (Surgical Intensive Care) 01/2024 - 11/2015
3	Platelet Transfusion (Blood Platelet Transfusions) 12/2023 - 10/2022
2	Length of Stay 11/2021 - 10/2020
2	Ligation 06/2014 - 11/2011
2	Punctures 06/2014 - 11/2011
1	Extracorporeal Membrane Oxygenation 01/2023
1	Cell Transplantation 01/2021
1	Percutaneous Coronary Intervention 01/2018
1	Organ Transplantation 12/2017
1	Cesarean Section (Caesarean Section) 03/2017
1	Anesthesia 11/2015